Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sanofi SA (NYSE:SNY)

45.35
Delayed Data
As of Mar 28
 -0.03 / -0.07%
Today’s Change
36.81
Today|||52-Week Range
45.95
+12.14%
Year-to-Date
Roche Wins FDA Backing for New Multiple Sclerosis Therapy, Competition Could Crimp Bi...
Mar 28 / TheStreet.com - Paid Partner Content
Sanofi Said to Be Near $1 Billion Deal for Flexion
Mar 23 / TheStreet.com - Paid Partner Content
VIVUS to Regain Commercial Rights for Stendra from Sanofi
Mar 28 / Zacks.com - Paid Partner Content
Merck Closes Acquisition of Controlling Stake in Vallee S.A
Mar 23 / Zacks.com - Paid Partner Content
Regeneron, Sanofi Score Eczema Drug Approval
Mar 28 / TheStreet.com - Paid Partner Content
Will Sanofi (SNY) Prove to be a Suitable Value Stock?
Mar 22 / Zacks.com - Paid Partner Content
How I'd Play Biotech Buyout Rumors
Mar 26 / TheStreet.com - Paid Partner Content
Amgen (AMGN): Repatha Outcomes Data Disappoint, Shares Drop
Mar 20 / Zacks.com - Paid Partner Content
How I'd Play Biotech Buyout Rumors
Mar 24 / TheStreet.com - Paid Partner Content
The Zacks Analyst Blog Highlights: U.S. Bancorp, Verizon, EOG Resources, Sanofi and N...
Mar 17 / Zacks.com - Paid Partner Content
How I'd Play Biotech Buyout Rumours
Mar 24 / TheStreet.com - Paid Partner Content
What are Sanofi's (SNY) Strengths and Challenges in 2017?
Mar 17 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Is Sanofi Buying Flexion? Pfizer, Merck KGaA Drug Approved
Mar 24 / Zacks.com - Paid Partner Content
Keryx Focuses on Kidney Drug Aurexia Despite Generic Threat
Mar 16 / Zacks.com - Paid Partner Content
Flexion (FLXN) Stock Soars 35% on $1 Billion Sanofi Buyout
Mar 23 / Zacks.com - Paid Partner Content
New Stock Research Reports for Verizon, EOG, and U.S. Bancorp
Mar 16 / Zacks.com - Paid Partner Content